OnCo

CCR4 is a chemokine receptor on skin-homing and regulatory T cells, and on the malignant cells of cutaneous T-cell lymphoma and adult T-cell leukaemia; mogamulizumab removes those cells. This dossier gathers the 1 product (1 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

GPCR expressed on Th2, Th17 and Treg cells and skin-homing T cells; chemotaxis to CCL17/CCL22 produced by dendritic cells and keratinocytes.

Where it is found
  • Mycosis fungoides / Sézary syndrome (>80%)
  • Adult T-cell leukaemia/lymphoma (~90%; 25% mutated)
  • Peripheral T-cell lymphoma (subset)
  • Tumour-infiltrating Tregs in solid tumours
Class: surface antigen · Gene: CCR4 · Facts checked 2026-09-08 · Target page

Elsewhere: identifiers and databases

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →
ModalityApproved
Antibody
1

No trial in the corpus names this target or one of its products.

Resistance routes that involve this target

Unaddressed routes →

The resistance atlas has no route that names this target.

Pathways where it is a node

Pathway-to-drug matrix →

No pathway diagram carries this target as a node.

Companion diagnostics and assays

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Key papers and the live literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"CCR4" OR ABSTRACT:"CCR4") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about CCR4, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/ccr4.json. Licence CC BY 4.0.